PTC Therapeutics, Inc. (PTCT) stock
PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)
Close on Nov 17, 2026Market cap $5.04BP/E –Yield –
PTC Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
PTC Therapeutics's market cap was $5.41B on Nov 11, 2026, against $6.87B a year earlier. Over the last 5 years it ranged from $1.41B to $6.87B, with a median of $3.30B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.41B | -10.9% |
| 2025 | Dec 31, 2025 | $6.07B | +74.8% |
| 2024 | Dec 31, 2024 | $3.47B | +67.0% |
| 2023 | Dec 29, 2023 | $2.08B | -24.2% |
| 2022 | Dec 30, 2022 | $2.74B | -2.6% |
| 2021 | Dec 31, 2021 | $2.81B | -32.0% |
| 2020 | Dec 31, 2020 | $4.14B | +39.9% |
| 2019 | Dec 31, 2019 | $2.96B | +70.9% |
| 2018 | Dec 31, 2018 | $1.73B | +150.3% |
| 2017 | Dec 29, 2017 | $691.60M | +85.5% |
| 2016 | Dec 30, 2016 | $372.75M | -66.1% |
| 2015 | Dec 31, 2015 | $1.10B | -27.7% |
| 2014 | Dec 31, 2014 | $1.52B | +276.5% |
| 2013 | Dec 31, 2013 | $403.94M | – |
See a number that looks wrong?